White Paper
An Evidence-Based Approach to Understanding the Benefits of Copay Reduction
This document discusses the impact of reducing copayments on medication adherence and healthcare costs. It highlights the correlation between high out-of-pocket (OOP) costs and poor medication adherence, which increases avoidable healthcare expenses. Studies show that lowering patient copays significantly boosts adherence, improves health outcomes, and reduces overall medical costs. Manufacturer and insurer-sponsored copay programs are effective in increasing medication adherence and reducing prescription abandonment. These programs are viewed positively by most patients and physicians and have the potential to reduce health disparities based on race and income.